Skip to main content
Clinical Trials/KCT0005516
KCT0005516
Recruiting
N/A

Establishment of clinical research platform based on dementia cohort

Samsung Medical Center0 sites300 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Samsung Medical Center
Enrollment
300
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Normal control group in the 65\-80s: Those who have normal results from health checkups, and cognitive tests (interview, neurological tests, neuropsychological tests, blood tests, brain MRI) and negative amyloid from the amyloid PET. Or asymptomatic Alzheimer's disease: Those who have normal results from health checkups, and cognitive tests (interview, neurological tests, neuropsychological tests, blood tests, brain MRI) but positive amyloid from the amyloid PET.
  • An elderly 65 years of age or older who meets both of the following conditions; (1\) If the clinical diagnosis based on neurological examination, medical history, brain MRI test, blood test (basic blood test, thyroid test, syphilis test, vitamin test) corresponds to mild cognitive impairment due to Alzheimer's disease, (2\) In the case of a positive for amyloid PET and confirmed as mild cognitive impairment due to Alzheimer's disease
  • An elderly 65 years of age or older who meets both of the following conditions; (1\) If the clinical diagnosis based on neurological examination, medical history, brain MRI test, blood test (basic blood test, thyroid test, syphilis test, vitamin test) corresponds to Alzheimer's disease dementia, (2\) Patients who test positive for amyloid PET and are diagnosed with Alzheimer's dementia

Exclusion Criteria

  • 1\) Patients with neurological abnormalities that may cause memory impairment on medical examination
  • 2\) Those who have a history of axis 1 psychiatric diseases including past intellectual disability, schizophrenia, alcoholism, and bipolar disorder
  • 3\) When it is judged that there is a problem in attaching the EEG and DC stimulation electrodes due to a deformity of the scalp, inflammatory reaction, or other dermatological problems
  • 4\) Stroke, convulsive history, current stroke or transient ischemia, convulsive disease, Parkinson's disease, multiple sclerosis, cerebral palsy, Huntington's disease, encephalitis, meningitis, diabetes which requires the insulin, poorly controlled hypertension, liver cirrhosis, or person receiving medical diagnosis and treatment that may interfere with the completion of this cognitive training program, such as kidney disease that requires dialysis
  • 5\) Those who have a history of malignant disease (cancer) within the last 3 years. However, cervical intraepithelial cancer or non\-melanoma skin cancer is excluded.
  • 6\) Those who have undergone cerebrovascular surgery, such as brain surgery or carotid artery surgery
  • 7\) Those who have difficulty breathing when sitting still
  • 8\) Persons with memory, language, or problem\-solving problems for more than 2 hours after a heart attack
  • 9\) Those with a history of hospitalization for mental or emotional illness within the last 5 years
  • 10\) Those with a history of abuse of drugs within the last 5 years

Outcomes

Primary Outcomes

Not specified

Similar Trials